Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review-Reference-Cited by-同舟云学术

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

Published:2008-07 Issue:1 Volume:27 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Akl Elie A,Barba Maddalena,Rohilla Sandeep,Terrenato Irene,Sperati Francesca,Muti Paola,Schünemann Holger J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1756-9966-27-21.pdf

Reference39 articles.

1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ: Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Archives of Internal Medicine. 2000, 160 (6): 809-815. 10.1001/archinte.160.6.809.

2. Gallus AS: Prevention of post-operative deep leg vein thrombosis in patients with cancer. Thromb Haemost. 1997, 78 (1): 126-132.

3. Kakkar VV, Howe CT, Nicolaides AN, Renney JT, Clarke MB: Deep vein thrombosis of the leg. Is there a "high risk" group? . American Journal of Surgery. 1970 , 120 (4): 527-530. 10.1016/S0002-9610(70)80023-X.

4. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA: Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data. Medicine. 1999, 78 (5): 285-291. 10.1097/00005792-199909000-00001.

5. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA: Prognosis of cancers associated with venous thromboembolism. New England Journal Of Medicine. 2000, 343 (25): 1846-1850. 10.1056/NEJM200012213432504.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Molecular-Weight Heparin Versus Warfarin in Adult Cancer Patients as a Precision Medicine for Thrombosis: A Systematic Review and Meta-Analysis;Cureus;2023-07-01

2. Venous Thromboembolism In Cancer Patients: “From Evidence to Care”;Clinical and Applied Thrombosis/Hemostasis;2022-01

3. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events;Journal for ImmunoTherapy of Cancer;2021-06

4. Heparanase in Cancer Metastasis – Heparin as a Potential Inhibitor of Cell Adhesion Molecules;Advances in Experimental Medicine and Biology;2020

5. Arrhythmias in Cancer Patients;Oncologic Critical Care;2019-10-13